NextCure, Inc. Share Price
NASDAQ: NXTC | Micro CapNextCure, Inc. Stock Performance
Open $6.09 | Prev. Close $6.08 | Circuit Range N/A |
Day Range $6.09 - $6.13 | Year Range $1.55 - $15.61 | Volume 339 |
Average Traded $6.11 |
NextCure, Inc. Share Price Today
As of 29 August 2026, NextCure, Inc.'s share price is $6.14. The stock opened at $6.09, compared to its previous close of $6.08. During today's trading session, NextCure, Inc.'s share price traded between $6.09 and $6.13, with an average price of $6.11. Over the past 52 weeks, the stock has recorded a high of $15.61 and a low of $1.55. In terms of performance, NextCure, Inc.'s share price has declined by 53.45% over the last six months and is up 18.17% on a year-on-year basis.
NextCure, Inc. Share Price Chart
NextCure, Inc. Stock Fundamentals & Key Indicators
Market Cap $17.47M | PE Ratio (TTM) -0.31 | Dividend Yield N/A |
EPS (TTM) $-19.65 | Revenue (TTM) N/A | Return On Equity (TTM) -159.81% |
Profit Margin N/A | Debt to Equity 0.30 | Quarterly Earnings Growth YoY 25.27% |
NextCure, Inc. Quarterly Profit & Loss
All figures in USD
NextCure, Inc. Annual Profit & Loss
All figures in USD
About NextCure, Inc.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NextCure, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.32 | $6.08 | +48.41% |
Jul 2026 | $1.85 | $4.10 | +149.24% |
Jun 2026 | $5.77 | $1.65 | -73.60% |
May 2026 | $9.80 | $6.23 | -33.37% |
Apr 2026 | $11.28 | $9.35 | -10.40% |
Mar 2026 | $12.19 | $10.44 | -20.95% |
Feb 2026 | $11.14 | $13.20 | +20.55% |
Jan 2026 | $13.43 | $10.95 | -23.80% |
Dec 2025 | $12.04 | $14.37 | +2.35% |
Nov 2025 | $9.53 | $14.04 | +11.69% |
Oct 2025 | $5.72 | $12.57 | +113.96% |
Sep 2025 | $4.87 | $5.88 | +12.98% |
NXTC Share Price FAQs
What is NextCure, Inc. share price today?
What is the 52 week high and 52 week low of NextCure, Inc. stock?
What is NXTC's market capitalisation today?
What is NXTC's net income for the last quarter?
What is the 5 year returns of NXTC?
What is the high & low stock price of NXTC today?
Can I buy NXTC shares in India?